LEASE AGREEMENT BETWEEN JUPITER HARBOUR OFFICE, LLC and DYADIC INTERNATIONAL (USA), INC.Lease Agreement • November 8th, 2023 • Dyadic International Inc • Biological products, (no disgnostic substances) • Florida
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionTHIS LEASE AGREEMENT (the "Lease'') is entered into as of the Execution Date defined below between JUPITER HARBOUR OFFICE, LLC (the "Landlord'') having an address of 1000 North U.S. Highway One, Suite 902, Jupiter, Florida 33477 and DYADIC INTERNATIONAL (USA), INC. a Florida Corporation having an address of 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 (the "Tenant''). The Landlord, in consideration of the rents and covenants to be kept and performed by the Tenant leases to the Tenant that certain property and improvements, more specifically described below, upon the following terms and conditions:
SERVICE FRAMEWORK AGREEMENTService Framework Agreement • November 8th, 2023 • Dyadic International Inc • Biological products, (no disgnostic substances) • Florida
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionThis SERVICE FRAMEWORK AGREEMENT (this "Agreement"), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 ("Dyadic"), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 4 7151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 ("BDI Pharmaceuticals"). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the "Parties" and individually as a "Party." Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.